Oliver Darlington

Statistics

Publications

Citations

409

H-Index

Active since

2020

Affiliations

Health Economics and Outcomes Research (United Kingdom)(Current)

AstraZeneca (Sweden)

AstraZeneca (United Kingdom)

University of Glasgow

University Medical Center Groningen

Oliver Darlington is an author at Health Economics and Outcomes Research (United Kingdom) specializing in cost-effectiveness analysis, chronic kidney disease, and pharmacotherapy.

Publications per year

2020–2022

Publications

Cost-Effectiveness of Dapagliflozin as a Treatment for Heart Failure with Reduced Ejection Fraction: A Multinational Health-Economic Analysis of DAPA-HF

Phil McEwan, Oliver Darlington, John J.V. McMurray et al. · European Journal of Heart Failure · 2020 · 155 citations · Full text

Pharmacy, Cardiology, Pharmacotherapy +17

The Impact of CKD Anaemia on Patients: Incidence, Risk Factors, and Clinical Outcomes—A Systematic Literature Review

Eirini Palaka, Susan Grandy, Heleen van Haalen et al. · International Journal of Nephrology · 2020 · 113 citations · Full text

Medicine, Hematology, Nephrology +16

Cost-Effectiveness of Dapagliflozin as a Treatment for Chronic Kidney Disease

Phil McEwan, Oliver Darlington, Ryan Miller et al. · Clinical Journal of the American Society of Nephrology · 2022 · 64 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +13

The public health impact of loneliness during the COVID-19 pandemic

James Allen, Oliver Darlington, Karen Hughes et al. · BMC Public Health · 2022 · 29 citations · Full text

Public Health, Health Sciences, Population Health Sciences +12

Estimating the Value of New Antimicrobials in the Context of Antimicrobial Resistance: Development and Application of a Dynamic Disease Transmission Model

Jason Gordon, Oliver Darlington, Phil McEwan et al. · PharmacoEconomics · 2020 · 25 citations · Full text

Pharmacy, Infectious Diseases, Pharmacoeconomics +14

1–5 of 7